StockData
Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc. (CRBU) stock

CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3074% below fair value
$0.34−0.01 (-3.43%)

Close on Nov 17, 2026Market cap $36.53MP/E –Yield –

Caribou Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Caribou Biosciences's price to book ratio was 0.4× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.3× to 2.2×, with a median of 1.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.6
2025Dec 31, 20251.0×+0.5
2024Dec 31, 20240.5×−0.8
2023Dec 29, 20231.3×+0.1
2022Dec 30, 20221.2×−1.1
2021Dec 31, 20212.2×–

More Caribou Biosciences figures

See a number that looks wrong?